DEA Eases Requirements for FDA-Approved Clinical Trials on Cannabidiol – POW420

Posted: January 9, 2016 in Cannabis, Constitution, Corruption, government, health, Marijuana, politics
Tags: , , , , , , , , , , , , ,

The United States Drug Enforcement Administration (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances Act (CSA) for those who are conducting FDA-approved clinical trials on cannabidiol (CBD), an extract of the marijuana plant.

Source: DEA Eases Requirements for FDA-Approved Clinical Trials on Cannabidiol – POW420

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s